Palo Alto Networks Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Palo Alto Networks Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jul 31, 2018 | $2.27B | Sep 13, 2018 |
| FY2018 | Jul 31, 2017 | $1.76B | Sep 13, 2018 |
| FY2018 | Jul 31, 2016 | $1.38B | Sep 13, 2018 |
| FY2017 | Jul 31, 2015 | $928.10M | Sep 7, 2017 |
| FY2016 | Jul 31, 2014 | $598.20M | Sep 8, 2016 |
| FY2015 | Jul 31, 2013 | $396.11M | Sep 17, 2015 |
| FY2014 | Jul 31, 2012 | $255.14M | Sep 18, 2014 |
| FY2013 | Jul 31, 2011 | $118.60M | Sep 25, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $9.22B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $8.03B | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $6.89B | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | $5.50B | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $4.26B | Sep 1, 2023 |
| FY2020 | Jul 31, 2020 | $950.40M | Sep 4, 2020 |
| FY2020 | Apr 30, 2020 | $869.40M | Sep 4, 2020 |
| FY2020 | Jan 31, 2020 | $816.70M | Sep 4, 2020 |
| FY2020 | Oct 31, 2019 | $771.90M | Sep 4, 2020 |
| FY2020 | Jul 31, 2019 | $805.80M | Sep 4, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jul 31, 2018 | $658.10M | Sep 13, 2018 |
| FY2018 | Apr 30, 2018 | $567.10M | Sep 13, 2018 |
| FY2018 | Jan 31, 2018 | $542.40M | Sep 13, 2018 |
| FY2018 | Oct 31, 2017 | $505.50M | Sep 13, 2018 |
| FY2018 | Jul 31, 2017 | $509.10M | Sep 13, 2018 |
| FY2018 | Apr 30, 2017 | $431.80M | Sep 13, 2018 |
| FY2018 | Jan 31, 2017 | $422.60M | Sep 13, 2018 |
| FY2018 | Oct 31, 2016 | $398.10M | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | $400.80M | Sep 7, 2017 |
| FY2017 | Apr 30, 2016 | $345.80M | Sep 7, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $6.77B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $5.97B | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $4.98B | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | $3.78B | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $2.98B | Sep 1, 2023 |
| FY2020 | Jul 31, 2020 | $660.00M | Sep 4, 2020 |
| FY2020 | Apr 30, 2020 | $611.10M | Sep 4, 2020 |
| FY2020 | Jan 31, 2020 | $583.60M | Sep 4, 2020 |
| FY2020 | Oct 31, 2019 | $554.20M | Sep 4, 2020 |
| FY2020 | Jul 31, 2019 | $588.40M | Sep 4, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.13B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $2.58B | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $439.70M | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | ($267.00M) | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | ($498.90M) | Sep 1, 2023 |
| FY2020 | Jul 31, 2020 | ($58.90M) | Sep 4, 2020 |
| FY2020 | Apr 30, 2020 | ($74.80M) | Sep 4, 2020 |
| FY2020 | Jan 31, 2020 | ($73.70M) | Sep 4, 2020 |
| FY2020 | Oct 31, 2019 | ($59.60M) | Sep 4, 2020 |
| FY2020 | Jul 31, 2019 | ($20.80M) | Sep 4, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.24B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $683.90M | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $387.30M | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | ($188.80M) | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | ($304.10M) | Sep 1, 2023 |
| FY2020 | Jul 31, 2020 | ($17.80M) | Sep 4, 2020 |
| FY2020 | Apr 30, 2020 | ($56.50M) | Sep 4, 2020 |
| FY2020 | Jan 31, 2020 | ($52.90M) | Sep 4, 2020 |
| FY2020 | Oct 31, 2019 | ($51.80M) | Sep 4, 2020 |
| FY2020 | Jul 31, 2019 | ($9.90M) | Sep 4, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.98B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $1.81B | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $1.60B | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | $1.42B | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $1.14B | Sep 1, 2023 |
| FY2020 | Jul 31, 2020 | $215.90M | Sep 4, 2020 |
| FY2020 | Apr 30, 2020 | $196.30M | Sep 4, 2020 |
| FY2020 | Jan 31, 2020 | $185.40M | Sep 4, 2020 |
| FY2020 | Oct 31, 2019 | $170.50M | Sep 4, 2020 |
| FY2020 | Jul 31, 2019 | $158.70M | Sep 4, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $3.72B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $3.26B | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $2.78B | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | $1.98B | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $1.50B | Sep 1, 2023 |
| FY2022 | Jul 31, 2020 | $1.04B | Sep 6, 2022 |
| FY2021 | Jul 31, 2019 | $1.06B | Sep 3, 2021 |
| FY2020 | Jul 31, 2018 | $1.04B | Sep 4, 2020 |
| FY2019 | Jul 31, 2017 | $868.80M | Sep 9, 2019 |
| FY2018 | Jul 31, 2016 | $658.60M | Sep 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $23.58B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $19.99B | Aug 29, 2025 |
| FY2024 | Jul 31, 2023 | $14.50B | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | $12.25B | Sep 1, 2023 |
| FY2022 | Jul 31, 2021 | $10.24B | Sep 6, 2022 |
| FY2021 | Jul 31, 2020 | $9.07B | Sep 3, 2021 |
| FY2020 | Jul 31, 2019 | $6.59B | Sep 4, 2020 |
| FY2019 | Jul 31, 2018 | $5.95B | Sep 9, 2019 |
| FY2018 | Jul 31, 2017 | $3.44B | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | $2.86B | Sep 7, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $15.75B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $14.82B | Aug 29, 2025 |
| FY2024 | Jul 31, 2023 | $12.75B | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | $12.04B | Sep 1, 2023 |
| FY2022 | Jul 31, 2021 | $9.48B | Sep 6, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $7.82B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $5.17B | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $1.75B | Aug 29, 2025 |
| FY2025 | Jul 31, 2022 | $210.00M | Aug 29, 2025 |
| FY2024 | Jul 31, 2021 | $634.50M | Sep 6, 2024 |
| FY2021 | Jul 31, 2020 | $1.10B | Sep 3, 2021 |
| FY2020 | Jul 31, 2019 | $1.59B | Sep 4, 2020 |
| FY2019 | Jul 31, 2018 | $1.16B | Sep 9, 2019 |
| FY2018 | Jul 31, 2017 | $759.60M | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | $894.90M | Sep 7, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $4.57B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $3.35B | Aug 29, 2025 |
| FY2024 | Jul 31, 2023 | $2.93B | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | $2.75B | Sep 1, 2023 |
| FY2022 | Jul 31, 2021 | $2.71B | Sep 6, 2022 |
| FY2021 | Jul 31, 2020 | $1.81B | Sep 3, 2021 |
| FY2020 | Jul 31, 2019 | $1.35B | Sep 4, 2020 |
| FY2019 | Jul 31, 2018 | $522.80M | Sep 9, 2019 |
| FY2018 | Jul 31, 2017 | $238.80M | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | $163.50M | Sep 7, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $2.48B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $1.35B | Aug 29, 2025 |
| FY2024 | Jul 31, 2023 | ($1.23B) | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | ($1.67B) | Sep 1, 2023 |
| FY2022 | Jul 31, 2021 | ($1.67B) | Sep 6, 2022 |
| FY2021 | Jul 31, 2020 | ($1.17B) | Sep 3, 2021 |
| FY2020 | Jul 31, 2019 | ($900.90M) | Sep 4, 2020 |
| FY2019 | Jul 31, 2018 | ($790.70M) | Sep 9, 2019 |
| FY2018 | Jul 31, 2017 | ($836.70M) | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | ($621.60M) | Sep 7, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $2.27B | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | $1.54B | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | $1.14B | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | $2.12B | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $1.87B | Sep 1, 2023 |
| FY2022 | Jul 31, 2020 | $2.96B | Sep 6, 2022 |
| FY2021 | Jul 31, 2019 | $961.40M | Sep 3, 2021 |
| FY2020 | Jul 31, 2018 | $2.51B | Sep 4, 2020 |
| FY2019 | Jul 31, 2017 | $744.30M | Sep 9, 2019 |
| FY2018 | Jul 31, 2016 | $734.40M | Sep 13, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jul 31, 2023 | $1.99B | Sep 1, 2023 |
| FY2023 | Jul 31, 2022 | $3.68B | Sep 1, 2023 |
| FY2022 | Jul 31, 2021 | $3.23B | Sep 6, 2022 |
| FY2021 | Jul 31, 2020 | $3.08B | Sep 3, 2021 |
| FY2020 | Jul 31, 2019 | $1.43B | Sep 4, 2020 |
| FY2019 | Jul 31, 2018 | $1.92B | Sep 9, 2019 |
| FY2018 | Jul 31, 2017 | $524.70M | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | $500.20M | Sep 7, 2017 |
| FY2016 | Jul 31, 2015 | $487.10M | Sep 8, 2016 |
| FY2015 | Jul 31, 2014 | $466.88M | Sep 17, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 1 | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | 4 | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | 0 | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | (1) | Sep 1, 2023 |
| FY2022 | Jul 31, 2020 | (2) | Sep 6, 2022 |
| FY2021 | Jul 31, 2019 | 0 | Sep 3, 2021 |
| FY2019 | Jul 31, 2018 | 0 | Sep 9, 2019 |
| FY2019 | Apr 30, 2018 | 0 | Sep 9, 2019 |
| FY2019 | Jan 31, 2018 | 0 | Sep 9, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 1 | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | 3 | Aug 29, 2025 |
| FY2025 | Jul 31, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Jul 31, 2022 | 0 | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | (1) | Sep 1, 2023 |
| FY2022 | Jul 31, 2020 | (2) | Sep 6, 2022 |
| FY2021 | Jul 31, 2019 | 0 | Sep 3, 2021 |
| FY2019 | Jul 31, 2018 | 0 | Sep 9, 2019 |
| FY2019 | Apr 30, 2018 | 0 | Sep 9, 2019 |
| FY2019 | Jan 31, 2018 | 0 | Sep 9, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 667.90M | Aug 29, 2025 |
| FY2025 | Jul 31, 2024 | 650.20M | Aug 29, 2025 |
| FY2024 | Jul 31, 2023 | 308.30M | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | 298.80M | Sep 1, 2023 |
| FY2022 | Jul 31, 2021 | 97.30M | Sep 6, 2022 |
| FY2021 | Jul 31, 2020 | 96.30M | Sep 3, 2021 |
| FY2020 | Jul 31, 2019 | 96.80M | Sep 4, 2020 |
| FY2019 | Jul 31, 2018 | 93.60M | Sep 9, 2019 |
| FY2018 | Jul 31, 2017 | 91.50M | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | 90.50M | Sep 7, 2017 |